Evgen Pharma, the clinical stage drug development company focused on cancer and neurological conditions, announced its interim results for the six months ended 30 September 2016. CEO Stephen Franklin joined Share Radio to talk on future projects and discuss the results.

CEO of Evgen Pharma on their interim results

Share Radio Breakfast is our flagship show and provides instant analysis of the company results, business and general news of the morning. ‘Breakfast’ is presented by Nigel Cassidy Monday, Thursday and Friday, and Sarah Lowther Tuesday and Wednesday,
From 6 am we reflect the breaking stories of the morning with interviews in the studio and on the phone. At 7am we are first with company news as announcements are released to the Stock Exchange. At 8am we bring you market reaction as stock trading begins, as well as instant opinions from a regular panel of experts on the phone and in the studio.
We have instant reaction and expert financial commentary from ex-fund manager Chris Bailey, Louise Cooper and Sara Sjolin. We follow the market opening before and after 8 am from David Buick at Panmure Gordon and Rachel Winter at Killicks. And at 8.20 each morning we put politics in context with Ryan Heath from Politico in Brussels, Dan Hodges, the Mail on Sunday, Josh Lowe of Newsweek, and Jack Sommers from the Huffington Post.

Business

Investing

Business News

Share Radio Breakfast is our flagship show and provides instant analysis of the company results, business and general news of the morning. ‘Breakfast’ is presented by Nigel Cassidy Monday, Thursday and Friday, and Sarah Lowther Tuesday and Wednesday, From 6 am we reflect the breaking stories of the morning with interviews in the studio and on the phone. At 7am we are first with company news as announcements are released to the Stock Exchange. At 8am we bring you market reaction as stock trading begins, as well as instant opinions from a regular panel of experts on the phone and in the studio. We have instant reaction and expert financial commentary from ex-fund manager Chris Bailey, Louise Cooper and Sara Sjolin. We follow the market opening before and after 8 am from David Buick at Panmure Gordon and Rachel Winter at Killicks. And at 8.20 each morning we put politics in context with Ryan Heath from Politico in Brussels, Dan Hodges, the Mail on Sunday, Josh Lowe of Newsweek, and Jack Sommers from the Huffington Post.

Share CEO of Evgen Pharma on their interim results

Sign up to save your podcasts

CEO of Evgen Pharma on their interim results

CEO of Evgen Pharma on their interim results